URGN:NASDAQ
Urogen Pharma Ltd
$26.85
arrow_downward
-2.72%(-0.75) 1D
$26.85
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for URGN...
Open
$27.39
High
$27.64
Low
$26.39
Mkt. cap
1.31B
Avg. vol.
823.78K
Volume
704.10K
52-wk high
$32.37
52-wk low
$5.24
EPS
-$2.75
Beta
1.59
Shares outstanding
48.72M
No. of employees
298
Open
$27.39
High
$27.64
Low
$26.39
Mkt. cap
1.31B
Avg. vol.
823.78K
Volume
704.10K
52-wk high
$32.37
52-wk low
$5.24
EPS
-$2.75
Beta
1.59
Shares outstanding
48.72M
No. of employees
298
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to URGN in the past 3 months
Strong Buy
Buy
7
Hold
1
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current $26.85
$45.00 (+67.60%)
Average
$36.63 (+36.42%)
Lowest
$18.00 (-32.96%)
News stories
From sources across the web
Investing.com
·
2 days ago
UroGen Pharma stock reaffirmed at Buy by H.C. Wainwright on Teva settlement
GuruFocus
·
2 days ago
URGN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $45
About Urogen Pharma Ltd
CEO-
Employees298
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com
AI content may include mistakes. Learn more